학술논문

Treatment of bone loss in osteopenic patients with Crohn's disease: A double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation
Document Type
Article
Source
In: Gut. (Gut, September 2014, 63(9):1424-1430)
Subject
Language
English
ISSN
14683288
00175749